Market closed

Avid Bioservices/$CDMO

14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX

About Avid Bioservices

Avid Bioservices Inc is a clinical-stage biopharmaceutical company focused on the development and Current Good Manufacturing Practices (CGMP) of biopharmaceutical products derived from mammalian cell culture. Its business is organized into one reportable operating segment which is contract manufacturing and development services segment. Its services include clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing and regulatory submissions support. The company also provides a variety of process development services including cell line development, upstream and downstream development and optimization, analytical method development, testing and characterization.

Ticker

$CDMO
Sector
Health Care
Trading on
NASDAQ

Industry

Biotechnology
Headquarters
Tustin, United States

Employees

-
Website
www.avidbio.com

Avid Bioservices Metrics

BasicAdvanced
$795M
-
-$2.39
1.41
-

$795M

1.41

$12.45

$5.90

1.1M

1.301

0.881

455.457

462.016

-2.30%

-3.27%

-133.29%

5.252

17.74

17.74

-81.623

6.75%

1,128.92%

12.28%

160.01%

What the Analysts think about Avid Bioservices

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Avid Bioservices stock.

Avid Bioservices Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Avid Bioservices Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-

Avid Bioservices News

AllArticlesVideos
The Schall Law Firm Invites Shareholders With Losses To Join An Inquiry Into Avid Bioservices, Inc. For Securities Fraud

The Schall Law Firm Invites Shareholders With Losses To Join An Inquiry Into Avid Bioservices, Inc. For Securities Fraud

Accesswire·20 hours ago
Avid Bioservices Inc Is Being Investigated For Securities Law Violations And Impacted Investors Are Urged To Contact The Schall Law Firm

Avid Bioservices Inc Is Being Investigated For Securities Law Violations And Impacted Investors Are Urged To Contact The Schall Law Firm

Accesswire·2 days ago
The Schall Law Firm Invites Shareholders With Losses To Join An Inquiry Into Avid Bioservices, Inc. For Securities Fraud

The Schall Law Firm Invites Shareholders With Losses To Join An Inquiry Into Avid Bioservices, Inc. For Securities Fraud

Accesswire·3 days ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $CDMO

$

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Avid Bioservices stock?

Avid Bioservices (CDMO) has a market cap of $795M as of January 15, 2025.

What is the P/E ratio for Avid Bioservices stock?

The price to earnings (P/E) ratio for Avid Bioservices (CDMO) stock is 0 as of January 15, 2025.

Does Avid Bioservices stock pay dividends?

No, Avid Bioservices (CDMO) stock does not pay dividends to its shareholders as of January 15, 2025.

When is the next Avid Bioservices dividend payment date?

Avid Bioservices (CDMO) stock does not pay dividends to its shareholders.

What is the beta indicator for Avid Bioservices?

Avid Bioservices (CDMO) has a beta rating of 1.41. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.